ArticleFrontiers in cellular and infection microbiology2025
Effect of PPD inoculation on serum cytokine profiles in latent tuberculosis infection populations.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the impact of PPD skin test administration on serum cytokine levels in individuals with latent tuberculosis infection (LTBI) compared to healthy controls. Through quantitative analysis of multiple cytokines in serum samples before and after testing, significant differences were observed in cytokine level changes among LTBI individuals following PPD stimulation. The results indicate that prior to PPD administration, there were no significant differences in cytokine levels between the LTBI group and healthy controls. However, following PPD testing, individuals with LTBI exhibited significantly elevated levels of β-NGF, Eotaxin, G-CSF, GRO-α, IL-10, IL-17A, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-6, IP-10, LIF, and SDF-1α, while MCP-1 levels were significantly reduced compared to those in healthy controls. Comparative analysis of different population groups before and after PPD skin test administration revealed no significant changes in serum levels of SCGF-β, G-CSF, MCP-3, or IL-3 among healthy controls. In contrast, individuals with latent tuberculosis infection (LTBI) exhibited significantly elevated levels of G-CSF, MCP-3, and IL-3, while SCGF-β levels were markedly reduced. This study provides novel insights into the differential immune responses to PPD testing in latent tuberculosis infection and identifies potential biomarkers for early monitoring of immune activation in tuberculosis infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.